Skip to main content

Table 1 Characteristics of included studies

From: Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis

First author, year (references)

Country

Sample size

Mean age, y

Male (%)

Surgery type

CLNM (%)

Risk factors

Gui, 2018 [14]

China

541

47.2

128 (23.7)

TT/LT + CLND

148 (27.4)

S, A, TS, M, ETE

Zhou, 2012 [9]

China

122

48.0

60 (49.2)

TT + CLND

60 (49.2)

S, A, TS

Yuan, 2017 [10]

China

295

43.0

89 (30.2)

TT/LT + CLND

125 (42.4)

A, M

Kim, 2012 [15]

Korea

160

47.3

19 (11.9)

TT + B-CLND

61 (38.1)

S, TS

Park, 2014 [16]

Korea

193

49.2

32 (16.6)

TT/LT + CLND

63 (32.6)

TS, M

Zhang, 2015 [11]

China

178

46.0

37 (20.8)

TT/LT + CLND

73 (41.0)

S, TS, ETE

Xu, 2014 [17]

China

402

45.4

79 (19.7)

TT/LT + CLND

156 (38.8)

TS, B, CI

So, 2010 [18]

Korea

551

50.2

111 (20.1)

TT + B-CLND

202 (36.7)

S, M, ETE

Caliskan, M 2012 [19]

Korea

842

46.3

73 (8.7)

TT/LT + CLND

218 (25.9)

TS, ETE

  1. CLNM central lymph node metastases, TT total thyroidectomy, LT lobectomy, CLND central lymph node dissection, B-CLND bilateral-central lymph node dissection, S sex, A age, TS tumor size, M multifocality, ETE extrathyroidal extension, B bilateral, CI capsule involvement